MRI Sans Biopsy Not Ready for Prime Time in Active Surveillance for Prostate Cancer

(MedPage Today) — Despite technologic advances and guideline recommendations, prostate MRI still lacks the accuracy to replace biopsies in active surveillance, data on almost 2,000 patients suggested.
MRI had a 75% negative predictive value …